Tendyne Holdings' Acquisition

Tendyne Holdings was acquired by Abbott on July 30, 2015.

Tendyne provides a transcatheter mitral valve replacement prosthesis for the treatment of both functional and degenerative mitral regurgitation. Its mitral valve is deployed and secured while preservi…

Articles about Tendyne Holdings' Acquisition: